Tarek Hassanien

5PUBLICATIONS
17CO-AUTHORS
Medical biochemistry - lipidsMicroelectromechanical systems (MEMS)Predictive and prognostic markersIntensive careCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.

Mohammad Honarvar, Julio Lobo, Caitlin Schneider

|Mar 22, 2024
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.

Rohit Loomba, Alnoor Ramji, Tarek Hassanein

|Jan 26, 2024
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.

Michael P Curry, Edward Tam, Caitlin Schneider

|Sep 06, 2022
Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.

Faouzi Saliba, Rafael Bañares, Fin Stolze Larsen

|Jul 25, 2022
Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.

Tarek Hassanein, Dean Tai, Chenghai Liu

Pageof 1